Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis

Clinical Nephrology

Volumn 46, Issue 3, 1996, Pages 183-186

  Bailey, R R ^a   Begg, E J ^a   Smith, A H ^a   Robson, R A ^a   Lynn, K L ^a   Chambers, S T ^a   Barclay, M L ^a   Hornibrook, J ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Acute pyelonephritis; Aminoglycosides; Antimicrobial agents; Ciprofloxacin; Gentamicin; Quinolones; Urinary tract infection

Indexed keywords

CIPROFLOXACIN; GENTAMICIN;

ACUTE PYELONEPHRITIS; ADULT; AGED; ARTICLE; AUDIOMETRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; OTOTOXICITY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GENTAMICINS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; PROSPECTIVE STUDIES; PYELONEPHRITIS;

EID: 0029792042     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bailey RR, Lynn KL, Peddie BA, Swainson CP 1985 Comparison of netilmicin with cefoperazone for the treatment of severe or complicated urinary tract infections. Aust NZ J Med 15: 22
2. Bailey RR, Lynn KL, Peddie BA, Walker RJ, Swainson CP 1986 Comparison of netilmicin with ceftriaxone for the treatment of severe or complicated urinary tract infections. NZ Med J 99: 459
3. Bailey RR, Lynn KL, Robson RA, Peddie BA 1989 Comparison of aztreonam (Azactam) and netilmicin in the treatment of severe or complicated urinary tract infections. Clinical Trials J 26: 288
4. Bailey RR, Lynn KL, Robson RA, Peddie BA, Smith A 1992 Comparison of ciprofloxacin with netilmicin for the treatment of acute pyelonephritis. NZ Med J 105: 102
5. Barclay ML, Begg EL 1994 Aminoglycoside toxicity and relation to dose regimen. Adv Drug React Toxic Rev 13: 207
6. Barclay ML, Begg EJ, Hickling KG 1994 What is the evidence for once-daily aminoglycoside therapy? Clin Pharmacokin 27: 32
7. Begg EJ, Atkinson HC, Jeffery GM, Taylor NW 1989 Individualised aminoglycoside dosage based on pharmacokinetic analysis is superior to dosage based on physician intuition at achieving target plasma drug concentrations. Br J Clin Pharmacol 28: 137
8. Begg EJ, Barclay ML, Duffull SB 1995 A suggested approach to once-daily aminoglycoside dosing. Br J Clin Pharmacol 39: 605
9. Caceres VM, Stange KC, Kikano GE, Zyzanski SJ 1994 The clinical utility of a day of hospital observation after switching from intravenous to oral antibiotic therapy in the treatment of pyelonephritis. J Fam Pract 39: 337
10. Cockcroft DW, Gault MH 1976 Prediction of creatinine clearance from serum creatinine. Nephron 16: 31
11. Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R 1995 Experience with a once-daily aminoglycoside program administered to 2184 adult patients. Antimicrob Agents Chemother 39: 650
12. Parker SE, Davey PG 1993 Once-daily aminoglycoside dosing. Lancet 341: 346
13. Pinson AC, Philbrick JT, Lindbeck GH, Schorling JB 1994 ED management of acute pyelonephritis in women: a cohort study. Amer J Emerg Med 2: 271
14. Prins JM, Büller HR, Kuijper EJ, Tange RA, Speelman P 1993 Once versus thrice daily gentamicin in patients with serious infections. Lancet 341: 335
15. Safrin S, Siegel D, Black D 1988 Pyelonephritis in adult women: inpatient versus outpatient therapy. Am J Med 85: 793
16. Ward G, Jordan RC, Severance HW 1991 Treatment of pyelonephritis in an observation unit. Ann Emerg Med 20: 258